MB-105 in Patients With CD5 Positive T-cell Lymphoma
MB-105 in Patients With CD5 Positive T-cell Lymphoma
Recruiting · NCT06534060 · Registry updated 2025-10-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MB-105 in Patients With CD5 Positive T-cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2025-10-03 | NCT06534060 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| March Biosciences Inc | 2 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor College of Medicine | Houston | United States | 306 |
| Cleveland Clinic | Cleveland | United States | 558 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Moffitt Cancer Center Magnolia Campus | Tampa | United States | 3 |
| Oregan Health & Science University | Portland | United States | 1 |
| SCRI - Colorado Blood Cancer Institute (CBCI) | Denver | United States | 1 |
| University of Iowa | Iowa City | United States | 284 |
| University of Nebraska | Omaha | United States | 13 |
| University of North Carolina at Chapel Hill | Chapel Hill | United States | 129 |
| University of San Diego (UCSD)-Moores Cancer Center | San Diego | United States | 1 |